Abstract
Activated pancreatic stellate cells (PSCs) play a central role in the tumor stroma of pancreatic ductal adenocarcinoma (PDAC). Given the limited availability of patient-derived PSCs from PDAC, immortalized PSC cell lines of murine and human origin have been established; however, it is not elucidated whether differences in species, organ disease status, donor age, and immortalization alter the PSC phenotype and behavior compared to that of patient-derived primary PSC cultures. Therefore, a panel of commonly used PSC cultures was examined for important phenotypical and functional features: three primary cultures from human PDAC, one primary from normal human pancreas, and three immortalized (one from human, two from murine pancreas). Growth rate was considerably lower in primary PSCs from human PDAC. Basal collagen synthesis varied between the PSC cultures, and TGF-β stimulation increased collagen synthesis only in non-immortalized cultures. Differences in secretome composition were observed along with a divergence in the DNA synthesis, migration, and response to gemcitabine of PDAC cell lines that were grown in conditioned medium from the various PSC cultures. The findings reveal considerable differences in features and functions that are key to PSCs and in the interactions with PDAC. These observations may be relevant to researchers when selecting the most appropriate PSC culture for their experiments.
Highlights
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with an overall 5-year survival of less than 7% [1]
Hematoxylin and eosin-based morphological analysis revealed different cell morphologies in the seven pancreatic stellate cells (PSCs) cultures: polygonal in human pancreatic stellate cells (hPSCs), long thin spindle-shaped in HPaSteC, small roundish in i-hPSC, and small stellate-shaped in i-mPSCs (Figure 1A)
The nuclei of i-hPSC were non-spherical, mostly cleaved and often horseshoe-shaped, and as such, they differed from the spherical nuclei that were observed in the other six PSC cultures
Summary
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with an overall 5-year survival of less than 7% [1]. The tumor stroma, which is exceedingly prominent in PDAC, plays an important role in treatment resistance [5], the exact mechanisms by which it contributes to drug resistance are currently poorly understood. The stroma was mainly considered a mere mechanical barrier to drug delivery [6], it is increasingly attributed a more active, multifaceted role, in which pancreatic stellate cells (PSCs) take center stage by exerting effects on the cancer cells through paracrine mechanisms as well as the production of various components of the extracellular matrix (ECM) [7,8,9,10]. While inhibition of the hedgehog pathway led to enhanced efficacy of gemcitabine in a mouse model [11], a clinical study with the same approach failed to show any benefit in patient outcome [12]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have